Treatments & Medications

Understanding the landscape of current FDA-approved drugs, therapies, and lifestyle approaches.

While there is currently no cure for Alzheimer's disease, there are medications that can temporarily slow the worsening of symptoms, and non-drug approaches that can meaningfully improve day-to-day quality of life.

Disease-Modifying Treatments

These newer drugs aim to change the underlying biology of the disease by targeting amyloid plaques in the brain.

Lecanemab (Leqembi)

Received traditional FDA approval in 2023. Shows promise in modestly slowing cognitive and functional decline in early-stage Alzheimer's by targeting amyloid plaques.

Donanemab (Kisunla)

Received traditional FDA approval in 2024. Clinical trials showed significant clearance of amyloid plaques in early Alzheimer's disease.

Aducanumab (Aduhelm)

The first therapy to demonstrate that removing amyloid from the brain is reasonably likely to reduce cognitive decline.

Treatments for Cognitive Symptoms

These drugs help manage memory loss, thinking, and reasoning problems rather than the underlying disease.

Cholinesterase inhibitors

Donepezil (Aricept), Rivastigmine (Exelon)

Prescribed to treat symptoms related to memory, thinking, language, judgment, and other thought processes.

Glutamate regulators

Memantine (Namenda)

Prescribed to improve memory, attention, reasoning, language, and the ability to perform simple tasks.

Non-Drug Approaches

Lifestyle interventions won't reverse the disease, but research links them to slower decline and better wellbeing.

Physical Exercise

Regular aerobic activity is linked to slower cognitive decline and improved mood and sleep quality.

Cognitive Stimulation

Puzzles, music therapy, and structured mental activities can help maintain cognitive function longer.

Social Engagement

Staying socially active reduces isolation, which is independently linked to faster cognitive decline.

Diet & Nutrition

Mediterranean and MIND diets rich in vegetables, fish, and healthy fats are associated with lower dementia risk.

Disclaimer: This information is for educational purposes only. Always consult a physician or a neurologist before starting, stopping, or changing any medication regimen.